论文信息 - The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags

The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags

Whereas genome sequencing defines the genetic potential of an organism, transcript sequencing defines the utilization of this potential and links the genome with most areas of biology. To exploit the information within the human genome in the fight against cancer, we have deposited some two million expressed sequence tags (ESTs) from human tumors and their corresponding normal tissues in the public databases. The data currently define ≈23,500 genes, of which only ≈1,250 are still represented only by ESTs. Examination of the EST coverage of known cancer-related (CR) genes reveals that <1% do not have corresponding ESTs, indicating that the representation of genes associated with commonly studied tumors is high. The careful recording of the origin of all ESTs we have produced has enabled detailed definition of where the genes they represent are expressed in the human body. More than 100,000 ESTs are available for seven tissues, indicating a surprising variability of gene usage that has led to the discovery of a significant number of genes with restricted expression, and that may thus be therapeutically useful. The ESTs also reveal novel nonsynonymous germline variants (although the one-pass nature of the data necessitates careful validation) and many alternatively spliced transcripts. Although widely exploited by the scientific community, vindicating our totally open source policy, the EST data generated still provide extensive information that remains to be systematically explored, and that may further facilitate progress toward both the understanding and treatment of human cancers.

[1] C. V. Jongeneel,et al. Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2] David States,et al. Selecting for functional alternative splices in ESTs. , 2002, Genome research.

[3] Christopher J. Lee,et al. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. , 2002, Nucleic acids research.

[4] Andrew J. Olson,et al. Computational analysis of alternative splicing using EST tissue information. , 2002, Genomics.

[5] Kenneth H Buetow,et al. An anatomy of normal and malignant gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6] C. V. Jongeneel,et al. Long-range heterogeneity at the 3' ends of human mRNAs. , 2002, Genome research.

[7] C. V. Jongeneel,et al. Nineteen additional unpredicted transcripts from human chromosome 21. , 2002, Genomics.

[8] S. Eddy. Computational Genomics of Noncoding RNA Genes , 2002, Cell.

[9] P. Bork,et al. Alternative splicing and genome complexity , 2002, Nature Genetics.

[10] R. Strausberg,et al. An international database and integrated analysis tools for the study of cancer gene expression , 2002, The Pharmacogenomics Journal.

[11] A. Simpson,et al. Alternative Spliced Transcripts as Cancer Markers , 2002, Disease markers.

[12] J. Kelso,et al. The contribution of exon-skipping events on chromosome 22 to protein coding diversity. , 2001, Genome research.

[13] Emmanuel Dias-Neto,et al. The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14] Christopher J. Lee,et al. Genome-wide detection of alternative splicing in expressed sequences of human genes , 2001, Nucleic Acids Res..

[15] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.

[16] É. Álvarez,et al. Splice variant expression of CD44 in patients with breast and ovarian cancer. , 2001, Oncology reports.

[17] S. Chun,et al. The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes. , 2000, Journal of Korean medical science.